Introduction to melanocytes and melanoma.
Clinical diagnosis and prognosis
Histology and histopathology
Molecular and (epi)genetic techniques
High throughput data analysis
Therapy, current clinical practice and preclinical advances
Major advances in basic research of melanoma have led to novel treatment options that are making a difference for melanoma patients. However, multiple challenges lie ahead and further progress is necessary, particularly with respect to resistance to the novel therapies. For advancing knowledge in the area and to ensure that future scientists are updated with respect to current knowledge in the field, we will host a course which teaches the basic biology and develoment of the melanocyte how these cells are transformed into melanoma, and how the disease is diagnosed and treated. A particular emphasis will be on novel therapeutic options and the resistance that arises against the new drugs.
The course is divided into two sessions, both will be held at the University of Iceland, in Reykjavik.
. 1st session: course (June 21-23) - register on Institut Curie website
. 2nd session: meeting (June 24-26) - register on the following website: www.melanoma2015.is
Scientists (PhD students and post-doc fellows, young group leaders in the field), MDs (Pathologists, Geneticists and Clinicians).
25 seats are open - “first come first served” basis.
University of Iceland
Room 131 in Askja
Beginning of May 2015
250€ (More information about payment procedure will be sent if you are selected.)
Participants can be accommodated in single rooms (120€/night). Accomodation will be provided at Fosshotel Hofdatorg, a new hotel near the center of Reykjavik. Further information will be given after the selection of the students. More information : http://www.fosshotel.is/hotels/fosshotel-in-reykjavik/fosshotel-reykjavik/
A few fellowships will be delivered to participants.
Lionel LARUE – Institut Curie, Orsay
Eirikur Steingrimsson – University of Iceland
Thorunn Rafnar - Decode Genetics, Reykjavik
Colin Goding - Ludwig Cancer Research, Oxford
In recent years, research into melanocytes and melanoma has led to giant steps in treatment of melanoma patients. The goal of this course is to teach students about the basic biology of melanoma with a particular emphasis on therapeutic options. The students will learn about this rapidly advancing field, and since the students will come from both the basic and clinical sciences, they will learn from each other in order to advance melanoma diagnosis and therapy in the future.
Hosting the course in Iceland will allow us to bring together European and American students and teach them about the latest advances in the field. This three day course will be followed by a three day meeting “Melanoma: from basic science to clinical applications“ (www.melanoma2015.is) where leaders in the field will talk about their latest results. This allows us to include some of the most important players in the field as teachers in the course.
The success of the course relies on the active contribution of participants who are expected to be proactive and to participate in all of the events organized including:
i) presentation of their own scientific project with a 10 minutes oral presentation, and
ii) participation in the "career development" workshop during the last day of the course.
The course will have a broad view of the melanocyte lineage, including the establishment of the lineage during embryonic development and the renewal of melanocytes from normal melanocyte stem cells. The similarities between the cellular and molecular mechanisms which occur during development, renewal and melanomagenesis will be explored for further clinical advancement. Lectures on epigenetics, genomics and clinical aspects of melanoma will bring a broader view of the field for the PhD students, postdoctoral fellows and junior scientists attending the course.
Lunches and dinners will be attended by both teachers and students giving opportunities for further discussions.
University of Iceland
Embassy of France in Iceland